| The histone variant H3. 3 in transcriptional regulation and human disease L Shi, H Wen, X Shi Journal of molecular biology 429 (13), 1934-1945, 2017 | 84 | 2017 |
| Histone H3. 3 G34 mutations alter histone H3K36 and H3K27 methylation in cis L Shi, J Shi, X Shi, W Li, H Wen Journal of molecular biology 430 (11), 1562-1565, 2018 | 82 | 2018 |
| Four amino acids guide the assembly or disassembly of Arabidopsis histone H3. 3-containing nucleosomes L Shi, J Wang, F Hong, DL Spector, Y Fang Proceedings of the National Academy of Sciences 108 (26), 10574-10578, 2011 | 73 | 2011 |
| Complementation of Hyponastic Leaves1 by Double-Strand RNA-Binding Domains of Dicer-Like1 in Nuclear Dicing Bodies Q Liu, Q Yan, Y Liu, F Hong, Z Sun, L Shi, Y Huang, Y Fang Plant physiology 163 (1), 108-117, 2013 | 37 | 2013 |
| Dicing bodies Q Liu, L Shi, Y Fang Plant Physiology 158 (1), 61-66, 2012 | 32 | 2012 |
| Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulators J Hou, Y Wang, L Shi, Y Chen, C Xu, A Saeedi, K Pan, R Bohat, NA Egan, ... Journal for immunotherapy of cancer 9 (2), 2021 | 25 | 2021 |
| LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade A Hickman, J Koetsier, T Kurtanich, MC Nielsen, G Winn, Y Wang, ... The Journal of clinical investigation 132 (13), 2022 | 20 | 2022 |
| Nucleolus-tethering system (NoTS) reveals that assembly of photobodies follows a self-organization model Y Liu, Q Liu, Q Yan, L Shi, Y Fang Molecular biology of the cell 25 (8), 1366-1373, 2014 | 18 | 2014 |
| Inhibiting type I arginine methyltransferase activity promotes T cell–mediated antitumor immune responses A Fedoriw, L Shi, S O'Brien, KN Smitheman, Y Wang, J Hou, C Sherk, ... Cancer immunology research 10 (4), 420-436, 2022 | 17 | 2022 |
| Histone variants: making structurally and functionally divergent nucleosomes and linkers in chromatin L Shi, Y Fang Frontiers in Biology 6, 93-101, 2011 | 2 | 2011 |
| Targeting PI3K isoforms to improve the effectiveness of T cell mediated immunotherapy R Bohat, X Liang, C Xu, Y Tang, J Hou, NA Egan, L Shi, A Guerrero, ... Cancer Research 83 (7_Supplement), 4444-4444, 2023 | | 2023 |
| 624 Targeting Type I arginine methyltransferases promotes T cell mediated antitumor immune responses L Shi, A Fedoriw, S O’Brien, K Smitheman, Y Wang, J Hou, C Sherk, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A654-A654, 2021 | | 2021 |
| 554 The panorama of tumor intrinsic immune regulators exhibited by genome-wide CRPISR immune screen integrated with comprehensive clinical dataset analysis J Hou, Y Wang, L Shi, Y Chen, C Xu, A Saeedi, K Pan, R Bohat, N Egan, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A584-A584, 2021 | | 2021 |
| The landscape of tumor intrinsic immune regulators revealed by genome-wide CRISPR immune screen integrated with comprehensive clinical data analysis J Hou, Y Wang, L Shi, Y Chen, C Xu, A Saeedi, K Pan, R Bohat, NA Egan, ... Cancer Research 81 (13_Supplement), 1575-1575, 2021 | | 2021 |
| Nucleolus-tethering System (NoTS) reveals the assembly of photobodies Y Liu, Q Liu, Q Yan, L Shi, Y Fang | | |
Hong WenVan Andel Research InstituteVerified email at vai.org
